INFECTION Clinical Trial
Official title:
Department of Pharmacy, Xijing Hospital
The investigators conducted the study in 4 teaching hospitals and 2 non-teaching hospitals
of Shaanxi Province. Surgeons, clinical pharmacists and nurses took part in patient
collection, information registration, protocol performance.
The investigators recruited 1200 patients with inguinal hernia undergoing inguinal
hernioplasty in the six hospitals from January 2010 to July 2011. The patients were randomly
allocated into control group, cefazolin group and levofloxacin group, with digital meter
method , 400 in each group. The data such as age, sex, case number, length of hospital stay,
antibiotic usage, post-operative infection, infection site, bacterial culture were filled in
self-designed forms on computer.
All of the patients received tension-free inguinal hernia repair with a mesh plug. The
surgical-site infection (SSI) was diagnosed according to the criteria of the Centers for
Disease Control and Prevention [5-6].
We chose cefazolin sodium and levofloxacin sodium chloride injection as peri-operative
antibiotics. Cefazolin sodium is an effective antibiotic with a short plasma elimination
half-life against gram-positive cocci (GPC) except for enterococci and meticillin-resistant
staphylococci. It is recommended as one of the prior antibacterial agents used for clearing
cuts and preventing infection in many countries including China. Levofloxacin sodium
chloride injection has a wide anti-bacterial spectrum composed of gram-negative bacteria and
gram-positive anaerobic bacteria including anaerobic bacteria. It can remain a high
concentration in urine, so it is recommended as an attractive antibiotic for urinary tract
operation [5].
In the control group, we gave normal saline as placebo by intravenous drip infusion for
30-60 min before operation. Cefazolin group and levofloxacin group received intravenous
administration of cefazolin sodium 1000 mg and levofloxacin sodium chloride injection 200
mg, respectively, for 30-60 min before operation.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
| Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
| Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
| Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
| Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
| Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
| Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
| Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
| Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
| Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
| Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
| Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
| Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
| Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
| Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
| Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
| Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
| Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
| Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
| Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |